<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03904615</url>
  </required_header>
  <id_info>
    <org_study_id>18-0247</org_study_id>
    <nct_id>NCT03904615</nct_id>
  </id_info>
  <brief_title>Geriatric Recovery Using Inpatient and Post-hospitalization Supplementation</brief_title>
  <acronym>GRIPS</acronym>
  <official_title>A Phase I Randomized Clinical Trial of In-hospital and Post-hospital Whey Protein vs. Low Quality Protein vs. Isocaloric Placebo Supplementation to Improve Recovery From Hospitalization in Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dairy Management Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Medical Branch, Galveston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the feasibility of nutritional interventions
      designed to help older patients maintain physical function after being in the hospital. We
      will test the feasibility and effect of nutritional interventions with whey protein, collagen
      or placebo on functional recovery from hospitalization in community dwelling older adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will compare in a randomized parallel design double blind pilot phase I study the
      feasibility of whey protein vs. collagen vs. isocaloric placebo supplementation in older
      adults during an acute hospitalization for a medical condition, and the treatments' effect
      size on physical function after hospital discharge.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 19, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel randomized double blind phase 1 trial of 3 interventions</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physical Function</measure>
    <time_frame>Change from baseline to 30 days after discharge</time_frame>
    <description>Short Physical Performance Battery (SPPB) scale, 0-12 points. 0=disabled; 12=high performance</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Whey Protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 g of whey protein twice daily during hospitalization and for 30 days after discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen Protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 g of collagen protein twice daily during hospitalization and for 30 days after discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>30 g of maltodextrin twice daily during hospitalization and for 30 days after discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey Protein</intervention_name>
    <description>30 g of whey protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge</description>
    <arm_group_label>Whey Protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Collagen Protein</intervention_name>
    <description>30 g of collagen protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge</description>
    <arm_group_label>Collagen Protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>30 g of maltodextrin in flavored water, twice daily, during hospitalization and for 30 days post-discharge</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 65 years or older.

          -  Admitted to UTMB hospital for any acute medical condition

          -  English speaking

        Exclusion Criteria:

          -  Inability to consent

          -  Bed or wheelchair bound prior to hospitalization

          -  Estimated creatinine clearance 20 ml/min or less, or end stage renal disease not on
             dialysis

          -  AST/ALT 2.5 times above the normal limit

          -  Active cancer

          -  Palliative care/Hospice

          -  Estimated protein intake &gt;1.2 g/kg/day during the previous 24 hours

          -  Any other condition or event considered exclusionary by the PI and faculty physician
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena Volpi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UTMB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elena Volpi, MD, PhD</last_name>
    <phone>4097721977</phone>
    <email>evolpi@utmb.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel Deer, PhD</last_name>
    <phone>4092669640</phone>
    <email>rrdeer@utmb.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UTMB Acute Care for Elders Unit</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77550</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Deer, PhD</last_name>
      <email>rrdeer@utmb.edu</email>
    </contact>
    <investigator>
      <last_name>Elena Volpi, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jennie Sealy Hospital</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rachel R Deer, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Roxana M Hirst, MS</last_name>
      <phone>4092669641</phone>
      <email>rmhirst@utmb.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 4, 2019</study_first_submitted>
  <study_first_submitted_qc>April 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2019</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No. This is a small Phase 1 feasibility pilot study. Risk of loss of confidentiality</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

